Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencySun, 02 Jun 2024 06:34:48 +0200Fri, 17 May 2024 11:08:00 +0200Human medicines European public assessment report (EPAR): Tracleer, bosentan, Date of authorisation: 14/05/2002, Revision: 44, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/tracleerHuman medicines European public assessment report (EPAR): Tracleer, bosentan, Date of authorisation: 14/05/2002, Revision: 44, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/tracleerFri, 17 May 2024 11:08:00 +0200Human medicineTracleer-H-C-PSUSA-00000425-201511 : EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation(s)https://www.ema.europa.eu/system/files/documents/scientific-conclusion/wc500218208_en.pdfTracleer-H-C-PSUSA-00000425-201511 : EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation(s)https://www.ema.europa.eu/system/files/documents/scientific-conclusion/wc500218208_en.pdfFri, 16 Dec 2016 01:00:00 +0100Human medicine